Dissolvable heart scaffolds take on drug balloons in major artery showdown

NCT ID NCT07162792

Not yet recruiting Disease control Sponsor: Xuzhou Third People's Hospital Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study will compare two modern treatments for blocked coronary arteries: a new-generation bioabsorbable scaffold (a temporary mesh that dissolves over time) and a drug-coated balloon (a balloon that releases medication to prevent re-blockage). 150 patients with blockages in large heart arteries will be randomly assigned to one of the two treatments. The main goal is to see which approach keeps the artery more open one year later, with follow-up continuing for five years.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: bioresorbable scaffold (Firesorb) and drug-coated balloon
What this could lead to: If successful, this could show that a dissolvable scaffold is a safe and effective alternative to drug-coated balloons for treating large heart arteries, potentially reducing the need for permanent implants.
What could go wrong: This is a relatively small, early-stage study (150 patients) that has not yet started recruiting. The results may not apply to all patients, and there is a risk that the scaffold could cause late complications like clotting or re-narrowing.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CORONARY ARTERY DISEASE (CAD) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

coronary artery disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CORONARY ARTERY DISEASE (CAD) DE NOVO CORONARY LESIONS

More trials for these conditions

Other studies related to the condition(s) this trial covers.